BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 36419185)

  • 1. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19.
    Karki R; Kanneganti TD
    J Transl Med; 2022 Nov; 20(1):542. PubMed ID: 36419185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    bioRxiv; 2020 Nov; ():. PubMed ID: 33140051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
    Lee S; Channappanavar R; Kanneganti TD
    Trends Immunol; 2020 Dec; 41(12):1083-1099. PubMed ID: 33153908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity: the first line of defense against SARS-CoV-2.
    Diamond MS; Kanneganti TD
    Nat Immunol; 2022 Feb; 23(2):165-176. PubMed ID: 35105981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
    Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
    Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
    Mahmoud IS; Jarrar YB; Febrimarsa
    Clin Exp Med; 2023 Oct; 23(6):2909-2923. PubMed ID: 37061574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammasomes and SARS-CoV-2 Infection.
    Kaivola J; Nyman TA; Matikainen S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection.
    Karki R; Lee S; Mall R; Pandian N; Wang Y; Sharma BR; Malireddi RS; Yang D; Trifkovic S; Steele JA; Connelly JP; Vishwanath G; Sasikala M; Reddy DN; Vogel P; Pruett-Miller SM; Webby R; Jonsson CB; Kanneganti TD
    Sci Immunol; 2022 Aug; 7(74):eabo6294. PubMed ID: 35587515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cell death, PANoptosis, screen identifies host factors in coronavirus innate immune response as therapeutic targets.
    Malireddi RKS; Bynigeri RR; Mall R; Connelly JP; Pruett-Miller SM; Kanneganti TD
    Commun Biol; 2023 Oct; 6(1):1071. PubMed ID: 37864059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis.
    Danladi J; Sabir H
    J Neuroimmunol; 2021 Sep; 358():577632. PubMed ID: 34186336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
    Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
    Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword.
    Tan LY; Komarasamy TV; Rmt Balasubramaniam V
    Front Immunol; 2021; 12():742941. PubMed ID: 34659238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
    Front Immunol; 2022; 13():832394. PubMed ID: 35464491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death.
    Zhu Z; Shi J; Li L; Wang J; Zhao Y; Ma H
    Front Immunol; 2022; 13():870216. PubMed ID: 35655782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.